Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $948,064 | $855,559 | $825,750 | $1,373,314 |
| - Cash | $54,480 | $35,604 | $62,545 | $64,365 |
| + Debt | $20,312 | $15,437 | $6,989 | $0 |
| Enterprise Value | $913,896 | $835,392 | $770,194 | $1,308,949 |
| Revenue | $201,611 | $174,535 | $150,349 | $111,700 |
| % Growth | 15.5% | 16.1% | 34.6% | – |
| Gross Profit | $136,737 | $116,894 | $103,249 | $79,855 |
| % Margin | 67.8% | 67% | 68.7% | 71.5% |
| EBITDA | $6,155 | $21,935 | -$5,363 | -$271,909 |
| % Margin | 3.1% | 12.6% | -3.6% | -243.4% |
| Net Income | $2,823 | $6,025 | -$13,263 | -$282,242 |
| % Margin | 1.4% | 3.5% | -8.8% | -252.7% |
| EPS Diluted | 0.013 | 0.072 | -0.1 | -4.3 |
| % Growth | -81.3% | 171.5% | 97.7% | – |
| Operating Cash Flow | $34,682 | $25,634 | $14,156 | -$318 |
| Capital Expenditures | -$3,635 | -$9,671 | -$7,931 | -$8,014 |
| Free Cash Flow | $31,047 | $15,963 | $6,225 | -$8,332 |